TLR8 and neoplasm: Decreased m6A levels on 5′‐half‐tRNA fragment (5′‐half)‐GlyGCC in EVs were identified as determinants of this effect and subsequent tumour progression, acting via Toll‐like receptor 8 (TLR8).